Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 00:12:09 UTC |
---|
Update Date | 2021-09-26 22:56:43 UTC |
---|
HMDB ID | HMDB0247190 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide |
---|
Description | N-(2-oxooxolan-3-yl)butanimidic acid belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. Based on a literature review very few articles have been published on N-(2-oxooxolan-3-yl)butanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(3s)-2-oxotetrahydrofuran-3-yl]butanamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | InChI=1S/C8H13NO3/c1-2-3-7(10)9-6-4-5-12-8(6)11/h6H,2-5H2,1H3,(H,9,10) |
---|
Synonyms | Value | Source |
---|
N-(2-Oxooxolan-3-yl)butanimidate | Generator | BHL-Serine | MeSH | BHL CPD | MeSH | C(4)-HSL | MeSH | N-Butanoyl-L-homoserine lactone | MeSH | N-Butyryl-L-homoserine lactone | MeSH | C4-HSL | MeSH | PAI-2 CPD | MeSH | Plasminogen activator inhibitor 2 | MeSH | N-Butyrylhomoserine lactone | MeSH | Serpin b2 | MeSH | Type 2 plasminogen activator inhibitor | MeSH | PAI-2 | MeSH |
|
---|
Chemical Formula | C8H13NO3 |
---|
Average Molecular Weight | 171.1937 |
---|
Monoisotopic Molecular Weight | 171.089543287 |
---|
IUPAC Name | N-(2-oxooxolan-3-yl)butanimidic acid |
---|
Traditional Name | Hsl |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCC(O)=NC1CCOC1=O |
---|
InChI Identifier | InChI=1S/C8H13NO3/c1-2-3-7(10)9-6-4-5-12-8(6)11/h6H,2-5H2,1H3,(H,9,10) |
---|
InChI Key | VFFNZZXXTGXBOG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | N-acyl-alpha amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid ester
- N-acyl-alpha amino acid or derivatives
- Acyl-homoserine lactone
- Fatty amide
- Gamma butyrolactone
- Fatty acyl
- N-acyl-amine
- Tetrahydrofuran
- Carboxamide group
- Carboxylic acid ester
- Lactone
- Secondary carboxylic acid amide
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide GC-MS (Non-derivatized) | splash10-00di-9500000000-4a7e6c83b313a1da727f | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide GC-MS (1 TMS) | splash10-00e9-3900000000-9d7551152f8bdd3ed1ae | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0096-9300000000-0e2e21cf9e828a428a6d | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 40V, Positive-QTOF | splash10-00di-9000000000-1cdedf48fbd42e5d2c34 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 20V, Positive-QTOF | splash10-00di-9200000000-c2a7ee8cb0fb4b131464 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 10V, Positive-QTOF | splash10-00di-9700000000-43634cb172ae189315e9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 10V, Positive-QTOF | splash10-0uk9-3900000000-e816c290903db83f013d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 20V, Positive-QTOF | splash10-0k96-9200000000-e1a4cc9b176f9d9a9d30 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 40V, Positive-QTOF | splash10-0006-9000000000-070b690f0c0195a185ff | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 10V, Negative-QTOF | splash10-00di-1900000000-ef9d9d63696bd19052f7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 20V, Negative-QTOF | splash10-0fdn-9700000000-527fbed17063a0e94df6 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide 40V, Negative-QTOF | splash10-0006-9100000000-d6fb762415c43b56f6dc | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
---|